Supplementary Figure 2 from Neoadjuvant Selicrelumab, an Agonist CD40 Antibody, Induces Changes in the Tumor Microenvironment in Patients with Resectable Pancreatic Cancer Katelyn T. Byrne , Courtney B. Betts , Rosemarie Mick , Shamilene Sivagnanam , David L. Bajor , Daniel A. Laheru , E. Gabriela Chiorean , Mark H. O'Hara , Shannon M. Liudahl , Craig Newcomb , Cécile Alanio , Ana P. Ferreira , Byung S. Park , Takuya Ohtani , Austin P. Huffman , Sara A. Väyrynen , Andressa Dias Costa , Judith C. Kaiser , Andreanne M. Lacroix , Colleen Redlinger , Martin Stern , Jonathan A. Nowak , E. John Wherry , Martin A. Cheever , Brian M. Wolpin , Emma E. Furth , Elizabeth M. Jaffee , Lisa M. Coussens , Robert H. Vonderheide crossref（2024）
摘要
Figure S2 shows the antibody panel and protocol, the gating strategy, and the immune cell populations identified using the mIHC platform.
更多 查看译文
AI 理解论文
溯源树
样例
